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Abstract
Background: Although it has received a degree of notoriety as a cause for antibiotic-associated enterocolitis (AAE),
the role of methicillin resistant Staphylococcus aureus (MRSA) in the pathogenesis of this disease remains enigmatic
despite a multitude of efforts, and previous studies have failed to conclude whether MRSA can cause AAE.
Numerous cases of AAE caused by MRSA have been reported from Japan; however, due to the fact that these
reports were written in the Japanese language and a good portion lacked scientific rigor, many of these reports went
unnoticed.
Methods: We conducted a systematic review of pertinent literatures to verify the existence of AAE caused by MRSA.
We modified and applied methods in common use today and used a total of 9 criteria to prove the existence of AAE
caused by Klebsiella oxytoca. MEDLINE/Pubmed, Excerpta Medica Database (EMBASE), the Cochrane Database of
Systematic Reviews, and the Japan Medical Abstract Society database were searched for studies published prior to
March 2013.
Results: A total of 1,999 articles were retrieved for evaluation. Forty-five case reports/series and 9 basic studies
were reviewed in detail. We successfully identified articles reporting AAE with pathological and microscopic findings
supporting MRSA as the etiological agent. We also found comparative studies involving the use of healthy subjects,
and studies detecting probable toxins. In addition, we found animal models in which enteritis was induced by
introducing MRSA from patients. Although we were unable to identify a single study that encompasses all of the
defined criteria, we were able to fulfill all 9 elements of the criteria by collectively analyzing multiple studies.
Conclusions: AAE caused by MRSA—although likely to be rarer than previous Japanese literatures have suggested—
most likely does exist.
Keywords: Methicillin-resistant Staphylococcus aureus, MRSA, Enterocolitis, Pseudomembranous colitis, Clostridium
difficile
Background
Although numerous papers have been published to date
on methicillin resistant Staphylococcus aureus (MRSA),
its role in the pathogenesis of antibiotic-associated en-
terocolitis remains unclear. During the 1950s, Staphylo-
coccus aureus was prime suspect in antibiotic-associated
pseudomembranous enterocolitis [1]; however, since the
identification of Clostridium difficile and its toxin as the
primary cause of pseudomembranous colitis in the
1970s, S. aureus has all but been exonerated from the
accusation [2-5]. In more recent years, the majority of
cases involving antibiotic-associated enterocolitis (AAE)
are considered to be caused by Clostridium difficile. In
most countries, MRSA as a potential cause of enterocoli-
tis is usually disregarded, if not rarely questioned [6,7].
On the opposite end of the spectrum, a fairly consistent
number of MRSA enterocolitis cases have been reported
from Japan since the late 1980s [8-10]. Unfortunately,
most of these literatures were published in the Japanese
language and therefore were rarely acknowledged by the
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greater international scientific community. The end re-
sult was the fueling of a misconception for AAE which
lingers to this day [11].
The reports on the so-called MRSA enterocolitis in
Japan may have misrepresented C. difficile infection
(CDI), since routine stool cultures often fail to identify C.
difficile. This is compounded by the fact that the mere
presence of MRSA in stool does not prove its pathogen-
icity. In addition, oral metronidazole had not been ap-
proved for treating CDI in Japan until 2012 [12]. In
previous years, oral vancomycin remained the only treat-
ment method available, and many physicians could have
mistakenly prescribed a treatment regimen for “MRSA
enterocolitis” when in fact they were treating CDI.
In order to elucidate the true causality of MRSA for
antibiotic-associated enterocolitis, and bridge the divide
on the understanding of AAE among different nations,
we conducted a systematic review on MRSA enterocoli-
tis associated with the use of antibiotics.
Methods
Search strategy and selection criteria
We systematically searched MEDLINE/PubMed, Embase,
the Cochrane Database of Systematic Reviews, and the
Japan Medical Abstract Society database for articles avail-
able on the subject prior to March 2013. The Japan Med-
ical Abstract Society database is the largest database for
medical articles in Japan and contains over 5,000 jour-
nals. The repository also consists of over 7.5 million pub-
lished articles and abstracts of scientific meetings dating
back to 1983, written mainly in the Japanese language
[13]. We decided to include this database since most re-
ports on MRSA enterocolitis are in fact from Japan but
written in the Japanese language and thus may hinder
their chances of inclusion in other noteworthy databases.
For Pubmed, Embase, and Cochrane, the keywords used
for searches included the following: ‘methicillin’/exp OR
methicillin AND resistant AND (‘staphylococcus’/exp OR
staphylococcus) AND aureus OR ‘mrsa’/exp OR mrsa
Figure 1 Study selection.
Iwata et al. BMC Infectious Diseases 2014, 14:247 Page 2 of 13
http://www.biomedcentral.com/1471-2334/14/247
AND (‘colitis’/exp OR colitis OR ‘enteritis’/exp OR enter-
itis OR ‘enterocolitis’/exp OR enterocolitis OR ‘diarrhea’/
exp OR diarrhea). For the Japan Medical Abstract Society
database, “methicillin resistant Staphylococcus aureus,”
or “MRSA” AND “choen” (meaning colitis in Japanese)
were used for the search. Retrieved reports were also
manually screened for further potentially relevant full ar-
ticles. We included studies written in languages other
than English, but excluded studies presented solely as ab-
stracts for scientific conferences.
Data extraction and evaluation
We included original articles in which antibiotic-
associated MRSA enterocolitis was described. To supple-
ment the clinical studies, we also sought basic scientific
studies such as those using animals to strengthen the ar-
gument for pathogenesis of AAE caused by MRSA, using
same search criteria. Eligible reports were independently
reviewed for evaluation by two authors (K. I. and D. A.),
who are both infectious diseases specialists, certified by
the Japanese Association for Infectious Diseases. K. I. is
also certified by the American Board of Internal Medi-
cine on both Internal Medicine and Infectious Diseases.
Any disputes were resolved by discussion between these
two parties.
In general, Koch’s postulates is used for proving a given
organism to be the pathogen of any given infectious dis-
ease; i.e., 1) the organism must be present in cases of the
disease, 2) the organism can be isolated from the diseased
host and grown in pure culture, 3) the organism from the
pure culture must cause the disease when inoculated into
a healthy subject, and 4) the organism must be re-
isolated from the diseased subject and shown to be the
same organism as the originally inoculated organism
[14]. Since MRSA can be found in the stool of healthy
subjects, we avoided simply applying Koch’s postulates to
prove causality. Likewise, we did not merely apply guide-
lines proposed for the diagnosis of acute bacterial diar-
rheal illnesses, since these were developed for pathogens
that readily cause outbreaks [14]. Rather, we modified
and applied the methods used by Högenauer et al. for
proving the causality of Klebsiella oxytoca as a cause of
AAE [15]; i.e., 1) exposure to antibiotics prior to the on-
set of diarrhea, 2) endoscopic findings consistent with
AAE, 3) Gram staining or other microscopic examination
of stool or colon consistent with AAE caused by Gram
Figure 2 “Studies fulfilling inclusion criteria” and “studies not fulfilling inclusion criteria”.
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positive cocci in cluster, 4) stool samples demonstrating
the presence of MRSA, while excluding other pathogens
such as Clostridium difficile, 5) comparison with healthy
subjects (modified to accommodate comparisons with pa-
tients with CDI), 6) toxin assay to identify potential/
plausible toxin(s), which is/are found in case but not in
control, 7) animal models, with histologic, microbiological
evidence of AAE caused by MRSA. We also added that;
8) patient’s condition improves after the use of anti-
MRSA agents [7], since it will strengthen the likelihood of
MRSA being the causative agent, unlike AAE caused by
K. oxytoca, which does not require specific treatment if
the causative antibiotic was discontinued. We also ex-
cluded cases of toxic shock syndrome (TSS) and food poi-
soning (Criterion 9). Although diarrhea is often observed
in TSS caused by Staphylococcus aureus, we considered
TSS a different entity from antibiotic-associated enterocoli-
tis. Similarly, we tried to distinguish reports of diarrhea,
suspected to be caused by food poisoning, which is a well-
known self-limiting disease caused by S. aureus but not to
be confused with antibiotic-associated enterocolitis—which
often requires specific antibiotic treatment.
We considered the use of selective, anaerobic stool
cultures for C. difficile as the ideal method to exclude
CDI since it is the most sensitive [16,17]. Absence of C.
difficile by conventional stool culture was not considered
sufficient to exclude CDI, since it has a low sensitivity.
Although the C. difficile toxin assay is frequently used
for the diagnosis of CDI in clinical settings, it lacks the
sensitivity to exclude CDI [16]. Therefore, we considered
the use of toxin assays as “moderate” evidence for exclu-
sion of CDI, and reports describing the use of these as-
says were discussed accordingly. The stool glutamate
dehydrogenase assay (GDH), a commonly used assay for
the diagnosis of CDI, has relatively high negative pre-
dictive value [18,19], and we considered that negative
GDH results could serve as moderate evidence for ex-
clusion of CDI. Until the late 2000’s, stool assays for
both toxin A (TcdA) and B (TcdB) were not available in
Japan, and the presence of TcdA only had been exam-
ined [20]. Since about 6% of C. difficile are non-TcdA
producing/TcdB producing (A-/B+), this was also taken
into consideration [20].
Conventional stool cultures often fail to identify C. dif-
ficile and exposure to antibiotics may leave MRSA as the
only identifiable pathogen. Therefore, we excluded stud-
ies merely finding MRSA in stool culture without specif-
ically attempting to exclude CDI.
Figure 3 The number of cases presented in published studies by year, both from “studies fulfilling inclusion criteria” and “studies not
fulfilling inclusion criteria”.
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Table 1 Summary of Case Records and Case Series on Antibiotic Associated Enterocolitis considered to be caused by MRSA


























1989 Japan 154 Somec No No Somed No Yes (SEC,
and TSST-1)
No Yes Some TSSs
McDonald
et al. [23].
1982 Australia 10 Yes Yes in 1 pt Yes Yes by CCFA cx
and TA
No No No Yes Yes
Christie
et al. [24].
1988 USA 1 No No No Yes by TAa Yes Yesb No Yes Yes
Sakamoto
et al. [25].





1991 Japan 34 Yes in 28 4 patients with autopsy
findings
No Yes by CCFA cx. No No No Yes No
Nakashio
et al. [27].
1991 Japan 1 No No No Yesd No Yes (SEC and
TSST-1)
No No Probably TSSf
Takeshima
et al. [28].
1991 Japan 16 Yes No No Yes by CCMA cx. No No No No Yes
Ueda et al.
[29].
1991 Japan 2 Yes No No Yes by GDH and
cx of unknown
methods.











1992 Japan 32 Yes No No Yes by TA and
cx of unknown
methods.
No Yes (SE and
TSST-1)




1993 Japan 1 Yes No Yes Yes by GDH No No No Yes Yes
Taylor et al.
[33].
1993 UK 1 Yes No No Yes by TA and
cx of unknown
methods.
No Yes (SEA) No Yes Yes
Takatera
et al. [34].
1994 Japan 2 Yes No No Yes by GDH No No No Yes Yes
Kuramoto
et al. [35].
1996 Japan 16 Yes No No Yes by TA Yes No No Yes Yes
Watanabe
et al. [36].
1996 Japan 9 Yes No No Yes by GDH and
cx of unknown
methods.




















Table 1 Summary of Case Records and Case Series on Antibiotic Associated Enterocolitis considered to be caused by MRSA (Continued)
Konishi
et al. [37].
1997 Japan 31 Probablyg No No Yes by cx of
unknown
methods.
No No No Yes Yes
Sakai et al.
[38].





No No No Yes
Yoshida
et al. [39].





Yes Yes by unknown
methods.
No Yes (SEC) No No Yes
Schiller et al.
[40].





















2000 Japan 1 No No No Yes by TA No Yes (TSST-1) No Yes Yes
Watanabe
et alj [43].














2002 Japan 13 Yes No No Yes by GDH No No No Yes Yes
Lee et al.
[46].
2003 S. Korea 1 Yes Yes Yes Yes by TA No No No Yes Yes
Fujita et al.
[47].
2004 Japan 1 Yes Autopsy findings c/w PC
with cocci
Yes Yes by GDH No No No No Nok
Yoshida
et al. [48].

























Table 1 Summary of Case Records and Case Series on Antibiotic Associated Enterocolitis considered to be caused by MRSA (Continued)
Froberg
et al. [49].












2005 Japan 1 Yes No No Yes by GDH No No No Yes No
Ackermann
et all [52].










2005 UK 1 Yes No No Yes by TA No No No Yes Yes
Boyce et al.
[54].


















2007 Japan 1 Yes No Yes Yes by GDH No No No Yes Yes
Nagao et al.
[57].










2007 Germany 29 Yes No No Yes by CCFA cx
and TA












Yes by TA No Yes (SEB,
SEC)





2008 Japan 18 UC No No Yes by TA With CDI No No Yes Yes
Tamura
et al. [61].
2008 Japan 10 Yes No No Yes by GDH With CDI No No Yes Yes

























2009 USA 5 Yes No No Yes by TA No No No Yes Yes
Fujii et al.
[64].
2010 Japan 1 UC No No Yes by TA No No No Yes Yes
Kitahata Y
et al. [65].
2011 Japan 1 Yes Yes No Yes by GDH No No No Yes Yes
Abbreviations: MRSA methicillin-resistant Staphylococcus aureus, c/w consistent with, AAE antibiotic associated enterocolitis, CDI Clostridium difficile infection, TSS toxic shock syndrome, pt patient, CCFA cycloserine-
cefoxitin-fructose agar, cx culture, TA toxin assay, SEC staphylococcal enterotoxin C, TSST-1 toxic shock syndrome toxin-1, CCMA cycloserine-cefoxitin-mannitol ager, GDH glutamate dehydrogenase assay, SEA staphylo-
coccal enterotoxin A, SE staphylococcal enterotoxins, SED staphylococcal enterotoxin D, SEB staphylococcal enterotoxin B, UC unclear, PC pseudomembranous colitis, CCEY cycloserine-cefoxitin egg yolk agar, SEE
staphylococcal enterotoxin E
a. There was no specification whether S. aureus in this article was indeed MRSA. However, the patient was treated with oral vancomycin, suggesting it was.
b. Cytopathic effects (CPE) were seen both via intracellular growth of S. aureus and with cell-free supernatant, suggesting the presence of toxin in S. aureus from the case. CPEs were not seen both in control S. aureus
and its supernatant.
c. Among the patients identified, the analysis was done for the use of antibiotics in 30 cases.
d. The article did refer to C. difficile but did not specify the methods to identify it.
e. Seventeen out of 34 patients did have concurrent C. difficile infection.
f. The patient developed septic shock with multiple organ failure, with identification of MRSA from multiple sites.
g. All cases are postoperative. Although there was no specific reference on the use of antibiotics, most patients in Japan usually receive varieties of antibiotics routinely after surgery, particularly in 1980s and 90s.
h. Randomly selected S. aureus isolates were used for comparison of toxin productions.
i. LukE-LukD are one of staphylococcal leukotoxin family [66].
j. It is possible that some patients in this paper might been described in reference 37 in duplicates.
k. The patient died of shock and organ failure. The blood culture after the death grew MRSA.






















The electronic search identified 2,315 titles (265 from
Pubmed, 1,326 from Embase, 0 from the Cochrane li-
brary, and 724 from the Japan Medical Abstract Society
database). All titles and abstracts were granted full re-
view (Figure 1).
Evaluation of included cases
A total of 152 case reports or case series on a combined
total of 1,463 patients were deemed relevant as a result
of the initial literature search. The number of articles
reporting MRSA enterocolitis has declined over the
years (Figure 2), and with that the number of reported
cases (Figure 3). Among the selected articles, 31 articles
were written in English, one was in Korean, and the
remaining 120 articles were written in Japanese. One-
hundred-twenty-four articles were from Japan (124/152,
81.6%). Within the 152 articles reviewed, 106 (106/152,
69.1%) were excluded on the basis that they simply diag-
nosed MRSA enterocolitis based on stool cultures, with-
out making reference to any attempts to exclude CDI.
One article written in Japanese [21] was judged to be a
duplicate of another case report published in English
[22] and therefore the former was removed from the
analysis. The remaining 45 articles were reviewed for the
pathogenicity of AAE caused by MRSA (Figure 1, and
Table 1).
Among these 45 articles, no single study fulfilled all 9
of the criteria we proposed (Table 2). The maximum
number of criteria fulfilled by a single study was 6 cri-
teria (6 studies), and the minimum was 2 (one study).
Only 8 studies utilized selective culture media for ex-
cluding CDI [23,26,28,41,52,54,55,58] and it should be
further noted that one of the articles described AAE due
to methicillin-sensitive S. aureus [52]. There was no ani-
mal study accompanying clinical data. Three studies
demonstrated the presence of cocci in pathological spec-
imens, which strongly suggested MRSA as being the
cause of enterocolitis [47,49,59]. Froberg et al. also de-
tected genes uniquely expressed in MRSA (mecA) in the
pseudomembrane [49]. Comparison with either stools
from healthy subjects, [24,35,36,41,54] or clinical fea-
tures with CDIs [38,52,55,58,60,61] were made in 11
studies. Eighteen studies provided data on toxin produc-
tion, such as enterotoxins, toxic shock syndrome toxin-1
(TSST-1), protease B, and leucotoxins (LukE-LukD). In
one study, the cytopathic effects (CPE) were observed
via both intracellular growth of S. aureus and with cell-
free supernatant, suggesting the presence of toxin in S.
aureus in the cases presented. CPEs were not observed
in either control S. aureus or its supernatant [24].
Basic studies including studies utilizing animal models
Basic studies including those using animal experiments
were also sought for analyses. We were able to retrieve 9
potential articles, which appeared relevant.
The oldest article we could retrieve was by van Pro-
haska [67]. He introduced S. aureus, isolated from pa-
tients with pseudomembranous enterocolitis or from
food implicated in human food poisoning, along with its
enterotoxins to chinchillas and cats and reproduced
pseudomembranous colitis, as confirmed by necropsy
[67]. Although he was able to demonstrate that S. aureus
and its enterotoxin could cause pseudomembranous en-
terocolitis in chinchillas, it is unlikely that MRSA or
AAE was the cause. Kawai used a rat model with or
without gastrectomy and introduced MRSA obtained
from patients with diarrhea (positive SEC, TSST-1) after
administering kanamycin and metronidazole. The same
study confirmed that MRSA multiplied in the rat intes-
tine but failed to demonstrate the occurrence of entero-
colitis [68]. Likewise, one study used a mouse model,
and showed that the use of ampicillin improved the
colonization of MRSA in the intestines. The same study,
however, did not directly examine the pathogenesis of
MRSA as the cause of enterocolitis [69]. Similar studies
reporting strikingly similar results were conducted by
different groups using mice [70], and rats [71]. Arima
used a rat model by introducing MRSA from a patient
with postoperative MRSA enterocolitis who had been
administered kanamycin and metronidazole. MRSA col-
onized in rat intestines, and after administrating lata-
moxef (oxacephem antibiotic) and cyclophosphamide,



















































38 10 11 45 11 18 0 34 34
Abbreviations: MRSA methicillin-resistant Staphylococcus aureus, c/w consistent with, AAE antibiotic associated enterocolitis, CDI Clostridium difficile infection, TSS
toxic shock syndrome.
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MRSA growth significantly increased, which ended in
bacteremia and metastatic infections to the liver, kid-
neys, and spleen [72]. Again, this paper also failed to
confirm the occurrence of enterocolitis induced by anti-
biotic treatment.
Nakamura et al. also reported a study using a mouse
model. After injecting cyclophosphamide and inducing
an immunocompromised state in mice, the group intro-
duced MRSA from patients with postoperative entero-
colitis into the jejunum of the mice. After injecting
ampicillin and moxalactam for 5 days, they succeeded in
producing severe diarrhea in mice, with histologically
confirmed inflammation in the jejunum [73]. Although
the experiment was rather artificial and the jejunum is
not a typical location for AAE, this study was the first—
to our knowledge—to histologically describe AAE
caused by MRSA in an animal model. A similar form of
regional enteritis was demonstrated by others practicing
the same method [74,75].
Discussion
Staphylococcal enterocolitis was first reported in 1942 in
an epidemic in a maternity unit [76]. Staphylococcal en-
terocolitis in association with the administration of anti-
biotics was first reported in 1948 [77]. Since then, cases
of AAE caused by S. aureus continued to be reported
[67,78,79] and by the end of the 1950s, S. aureus was
considered to be one of the major causes of AAE [80].
However, since Clostridium difficile and its toxin were
found to be associated with antibiotic-associated pseudo-
membranous colitis [2-5], the significance of S. aureus
was all but marginalized. John G. Bartlett, one of the
world’s most well-known infectious diseases specialists
and one of the discoverers of C. difficile as the cause of
pseudomembranous colitis, stated that, “Staph. aureus
was implicated as the chief cause of antibiotic-associated
pseudomembranous enterocolitis in the 1950s. It is un-
clear whether this finding represented misdiagnosis of C.
difficile infection or Staph. aureus caused a different dis-
ease” [1], implying that AAE by S. aureus might not exist,
but instead CDI with positive MRSA cultures could have
been misinterpreted as AAE by MRSA. Subsequently,
routine stool cultures in the hospital setting were discon-
tinued in the United States [81], and physicians virtually
ceased to seek out S. aureus as a cause of AAE. Only the
C. difficile toxin assay became the method for diagnosing
AAE [16]. The world’s leading textbooks on both Internal
Medicine and Infectious Diseases no longer refer to S.
aureus as a cause of AAE [82,83]. UpToDate and
DynaMed, both popular electronic clinical resources, do
not lead to sections related to MRSA enterocolitis by
using keywords such as “antibiotic associated diarrhea,”
or “staphylococcus aureus” (as of May 23, 2013). The In-
fectious Diseases Society of America, or IDSA, guidelines
published on MRSA also has no mention of enterocolitis
associated with this particular pathogen [84].
In contrast, numerous articles on MRSA enterocolitis
have been published from Japan since the late 1980’s, as
shown in our systematic review. Most were written in
the Japanese language and consequently went largely un-
noticed overseas. To add to the dilemma, most studies
published in Japan failed to exclude CDI from the differ-
ential. Many failed to make any attempt at searching for
C. difficile and some used less sensitive tests, such as
GDH assays as exclusion criteria for CDI. A C. difficile
toxin assay for both CdtA and CdtB was approved in
2007 in Japan [20,85], however, prior to this assays for
only CdtA had been used, and many studies claiming to
have excluded CDI by toxin assay might have failed to
detect CDI producing only CdtB. Furthermore, metro-
nidazole was not approved for the treatment of CDI
until 2012 in Japan [12], and oral vancomycin was the
only antibiotic used for the treatment of AAE. Consist-
ent with Bartnett’s implication, this may have resulted in
confusion, which erroneously lead physicians to believe
that they were treating MRSA enterocolitis. The lack of
similar reports abroad, as well as the lack of studies with
scientific rigor cultivated a sense of skepticism to spread
amongst Japanese physicians. To add fuel to this
skepticism, articles regarding AAE by MRSA, even from
Japan, have declined in recent years.
But does this mean that AAE caused by MRSA simply
does not exist, and that the apparent epidemic in Japan
can be traced to mere ill-definition?
Our answer, based on this systemic review is both
“yes” and “no.” While largely ignored in many countries
such as the United States, the current systematic review
suggests AAE by MRSA most likely exists. Likewise, the
majority of cases reported from Japan were probably not
AAE by MRSA, and many of these cases were simply a
misdiagnosis of CDI (with occasionally different causa-
tive entities such as TSS).
In more recent years, experts in both Europe and the
USA have rekindled their interests in S. aureus as a po-
tential cause for AAE [62,86-88]. It is also important to
note that other pathogens such as Klebsiella oxytoca
have also been found to cause AAE [15].
Our investigation ultimately failed to show any single
study on AAE caused by MRSA matching the scientific
rigor embodied in the report published by Högenauer
et al. for the diagnosis of AAE by K. oxytoca, which col-
lected clinical cases, examined cytotoxin produced by K.
oxytoca, compared stool samples with that from healthy
subjects, and even established an in vivo animal model
[15]. However, our systematic review could fulfill all of
the established criteria by collectively analyzing data from
multiple studies. We found clinical cases of enterocolitis
associated with antibiotic use. Studies demonstrated the
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existence of MRSA in patients, while excluding CDI with
sensitive culture media. There was histopathological con-
firmation on the presence of Gram positive cocci in le-
sions with inflammation from patients with AAE, which
makes the argument for misinterpretation of CDI very
unlikely. Comparisons with stool from healthy subjects
were conducted, production of toxins was demonstrated,
and animal models were established. Even though MRSA
enterocolitis associated with antibiotic use may not be all
that common—which is in stark contrast to what Japa-
nese physicians had believed until recently—it probably
does exist to some extent.
Our review has several inherent limitations. First, we
may not have been able to identify all relevant studies,
although the independent selection of studies, including
those written in non-English language from the Japan
Medical Abstract Society database, by two independent
reviewers suggests adequate identification among pub-
lished literatures. Likewise, we did not search for unpub-
lished literatures, which could have relevance to our
study. Second, although we were able to fulfill the cri-
teria for the presence of AAE caused by MRSA collect-
ively, no single study independently did so, which
slightly weakens the validity of our hypothesis. Third,
even if AAE caused by MRSA truly exists, we were un-
able to demonstrate its clinical significance, including its
incidence, clinical characteristics, risk factors, economic
impacts, and its consequence such as mortality. Flem-
ming et al. identified MRSA in 29 out of 2,727 stool
samples (1.1%) of nosocomial diarrhea [58], implying
that AAE caused by MRSA is relatively rare, but not ex-
tremely uncommon. However, it is well known that the
prevalence of MRSA differs significantly from one coun-
try to the other [89], and elucidation of the exact inci-
dence of AAE by MRSA warrants independent
investigation in each geographical region or country.
These clinically relevant agendas should be evaluated in
future studies.
Conclusions
Even though many cases reported mainly from Japan by
themselves failed to verify the existence of Antibiotic As-
sociated Enterocolitis caused by MRSA, our systematic
review suggests it does probably exist.
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